ClinicalTrials.Veeva

Menu

Immune Response Features in Allergic Airway Diseases

L

Lithuanian University of Health Sciences

Status

Unknown

Conditions

Allergic Rhinitis
Allergic Asthma

Treatments

Procedure: Nasal provocation test

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to investigate immune mechanisms and phenotypes and endotypes of allergic airway diseases - allergic rhinitis and allergic asthma. Pathogenesis of these diseases are not fully investigated yet. Patients with the same disease have different dominant symptoms, course of the disease and response to treatment. Moreover, there is a hypothesis about united airway disease suggesting that allergic rhinitis and allergic asthma is different manifestation of the same disease. This led to assumption of phenotypes and endotypes. This classification which still is not unified can let to prescribe personalized treatment for every patient.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Hypersensitivity to house dust mites
  • Allergic rhinitis with or without mild to moderate asthma

Exclusion criteria

  • Acute or chronic infections
  • Use of systemic immunosupresants (wait 1 month)
  • Use of systemic or local antihistamines (wait 1 week)
  • Use of intranasal steroids (wait 1 month)
  • Oncological or active autoimmune diseases

Trial design

150 participants in 3 patient groups

Allergic rhinitis patients
Treatment:
Procedure: Nasal provocation test
Allergic rhinitis and asthma patients
Treatment:
Procedure: Nasal provocation test
Healthy individuals
Treatment:
Procedure: Nasal provocation test

Trial contacts and locations

1

Loading...

Central trial contact

Laura Tamasauskiene, MD; Brigita Sitkauskiene

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems